Gastric- and intestinal-type IPMN: two of a kind?
Sign Up to like & getrecommendations! Published in 2020 at "Virchows Archiv"
DOI: 10.1007/s00428-020-02827-3
Abstract: Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions to pancreatic cancer. They consist of cystically dilated ducts that are clinically detectable by imaging and are lined by neoplastic epithelium. Their detectability, relative frequent occurrence in… read more here.
Keywords: intestinal type; type ipmn; ipmns; ipmn ... See more keywords
Pancreatic ductal adenocarcinomas associated with intraductal papillary mucinous neoplasms (IPMNs) versus pseudo-IPMNs: relative frequency, clinicopathologic characteristics and differential diagnosis
Sign Up to like & getrecommendations! Published in 2021 at "Modern Pathology"
DOI: 10.1038/s41379-021-00902-x
Abstract: The literature is highly conflicted on what percentage of pancreatic ductal adenocarcinomas (PDACs) arise in association with intraductal papillary mucinous neoplasms (IPMNs). Some studies have claimed that even small (Sendai-negative) IPMNs frequently lead to PDAC.… read more here.
Keywords: pseudo ipmns; pdacs; frequency; pathology ... See more keywords
The quantum physics of intraductal papillary mucinous neoplasm of the pancreas
Sign Up to like & getrecommendations! Published in 2022 at "BJS Open"
DOI: 10.1093/bjsopen/zrac082
Abstract: In 1997, a 54 year old woman underwent pancreatoduodenectomy at Verona University Hospital for a 3-cm periampullary cyst with a solid component. The final pathology reported a peripheral intraductal papillary mucinous neoplasm (IPMN) with low-grade… read more here.
Keywords: time; ipmns; physics; pathology ... See more keywords
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs.
Sign Up to like & getrecommendations! Published in 2022 at "Carcinogenesis"
DOI: 10.1093/carcin/bgac051
Abstract: Intraductal papillary mucinous neoplasms (IPMNs) are non-obligatory precursor lesions of pancreatic ductal adenocarcinoma (PDAC). The identification of molecular biomarkers able to predict the risk of progression of IPMNs toward malignancy is largely lacking and sorely… read more here.
Keywords: increased risk; ipmns; genetically determined; risk ... See more keywords
Pancreatic Neuroendocrine Tumor Abnormally Secreting Procalcitonin.
Sign Up to like & getrecommendations! Published in 2017 at "Pancreas"
DOI: 10.1097/mpa.0000000000000708
Abstract: mutations appear as an early event in the neoplastic transformation of IPMNs regarding almost half of the IPMN cases. Concerning those cases, it remains nevertheless unclear ifKRASmutations may give IPMNs as precursor lesions a malignant… read more here.
Keywords: pancreatic neuroendocrine; abnormally secreting; neuroendocrine tumor; tumor abnormally ... See more keywords
Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
Sign Up to like & getrecommendations! Published in 2017 at "Anticancer research"
DOI: 10.21873/anticanres.11553
Abstract: Intraductal papillary mucinous neoplasms (IPMNs) are presumed to evolve from low-grade dysplasia to high-grade dysplasia to invasive carcinoma. Resection of lesions before the development of pancreatic cancer may prevent the development of an incurable process… read more here.
Keywords: papillary mucinous; grade dysplasia; ipmns; malignant progression ... See more keywords